The summer was one of the most profitable on record for us, too. In fact, since May, here are just some of the wins collected by subscribers: Bovie Medical Corporation (BVX) up 159% Rigel Pharmaceuticals (RIGL) up 29% Goldfield Corporation (GV) up 106% MeetMe Inc. (MEET) up 135% Adverum Biotechnologies (ADVM) up 37% Groupon Inc.…
DetailsThe pharmaceuticals industry is no stranger to controversy. Plagued with runaway drug prices that have drawn the ire of Americans, the industry has come under fire, most recently from Democratic presidential nominee Hillary Clinton. But it’s not just the high cost of drugs that’s upset her. It’s also the high cost of drug delivery systems.…
Details$106,848 That’s how much it cost to run a full page ad in Section C of the New York Times. A big layout for most businesses. It’s easily justified cost for a wide-release movie. It can also be absorbed in the “branding” efforts of a big companies like Samsung who spend as much as $15…
DetailsBiotech is back…it seems. The NASDAQ Biotechnology Index is up 19% in the last month. However, I’ve got to warn you, a year and a half into the correction, I’m still not buying it at all. Here’s why. The Hidden Biotech Bust In March 2015 your editor warned: The risk/reward of biotech stocks as a…
DetailsIn early April 2016, we noted, “Biotech may have had a rough start to the year, lagging many other sectors. But don’t count it out just yet. In fact, buy all you can. The same strong catalysts and fundamentals are still firmly in place. Even though the first quarter of 2016 showed slower M&A activity,…
Details“This is a vote that changes everything.” That’s the quote we took the Financial Times following the Brexit referendum. It has now been two months since the Brexit was approved by voters and, in a way, everything has changed. Running With The Herd We felt a little bit like we were losing our minds watching…
DetailsThe last time the Federal Reserve raised the interest rate was in December 2015. At the time, the central bank was confident the economy was strong enough to handle higher borrowing costs. But as they learned soon after, they were wrong. Their optimism was premature. The economy wasn’t ready. World markets plunged thousands of points,…
DetailsIt’s looking like a nose-to-nose fight to the finish. At the moment, 41% of Americans are in favor of Hillary Clinton. Another 37% backs Donald Trump. About 10% are in favor of Libertarian candidate Gary Johnson, and another 4% in favor of Green Party candidate Jill Stein. But it’s the main contenders that are generating…
DetailsIt’s my favorite time of year. Yes, I live in Scottsdale, Arizona. It’s August. The heat is unbearable. The town grounds to a halt when it passed 110 degrees. The only way to get things done outside is when it’s in the low 80s well before 6:00 AM. But that’s not why you’ll see me…
DetailsThe financial world is completely upside down. Government bonds have negative yields. Banks are only avoiding charging negative interest rates (which would be charging you money for holding your money) by adding and hiking fees. The average mortgage rate is 2.67%. That’s a full 1% below the rate of inflation if you calculate inflation using…
DetailsDow Jones 36,000 may remain a pipe dream. But analyst expectations for 20,000 could soon be reality. In fact, as of last week, the consensus one-year estimate on Wall Street is now 20,003.93, up from an earlier projection of 19,914. And it’s not as farfetched as you’d think especially in such a low interest rate…
DetailsIt’s a nail biting fight to the finish. In just three months, either Hillary Clinton or Donald Trump will be elected the next president of the United States. At the moment, 43% of voters are in favor of Clinton. Another 40% are likely to vote from Trump. Libertarian Gary Johnson has about 8% favorability while…
Details